Researchers believe her incredibly rare chromosomal mutation could unlock the next generation of painkillers.

Researchers from the University College London have brought us one step closer to understanding how we feel pain. Their study, published in Brain, describes a rare genetic mutation found in a patient ...

The research and development arm of Janssen Pharmaceuticals, a Johnson & Johnson company, announced on Sunday (January 17) their voluntary suspension of dosing in two Phase 2 clinical trials of their ...

Chronic cannabis users have reduced levels of an enzyme called fatty acid amide hydrolase (FAAH). The enzyme has been considered for treatment for cannabis dependence because it breaks down substances ...

Doctors in Scotland were amazed when a 66-year-old woman underwent what is normally a very painful operation on her hand for severe arthritis and required little to no pain medication afterward.

The cannabinoid receptor (CB1), the G protein-coupled receptor activated by the psychotropic components of marijuana, is an attractive target for the development of anxiety- and pain-reducing ...

Figure 1: An overview of the endocannabinoid pathway and molecules tested in this study. “This study explores the functional relevance and therapeutic potential of FAAH inhibition combined with the ...

The US Food and Drug Administration (FDA) has concluded that the toxicity of an experimental medicine in development to treat a host of clinical conditions, including hypertension and obesity, does ...

DUBLIN and STAMFORD, Conn., Oct. 26, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX) ("SpringWorks ...

Encouraging Topline Data From Phase 1 Study of IPI-940 Reported Decision Demonstrates Strength of Alliance and Underscores Complementary Capabilities of the Partners CAMBRIDGE, Mass., Oct. 26, 2010 ...